Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects
J Am Soc Nephrol
.
2024 Jan 1;35(1):130.
doi: 10.1681/ASN.0000000000000226.
Authors
Sunjae Bae
1
,
Mara A McAdams-DeMarco
Affiliation
1
Department of Surgery, NYU Grossman School of Medicine, New York, New York and Department of Population Health, NYU Grossman School of Medicine, New York, New York.
PMID:
38170603
PMCID:
PMC10881186
(available on
2025-01-01
)
DOI:
10.1681/ASN.0000000000000226
No abstract available
MeSH terms
Humans
Immunosuppressive Agents* / adverse effects
Kidney Transplantation*
Lipids
Substances
Immunosuppressive Agents
Lipids
Grants and funding
K01 DK132490/DK/NIDDK NIH HHS/United States
R01 DK120518/DK/NIDDK NIH HHS/United States
K01DK132490/DK/NIDDK NIH HHS/United States
R01DK120518/DK/NIDDK NIH HHS/United States